Prevalence of Frailty Among People Aged 75 and Over Living at Home

The aging of population lead to study ways to prevent dependence. Frailty is a precursor to dependence which can be reversible. In the literature, estimate of prevalence of frailty is highly variable depending on the frailty definition, the population studied and the screan tool used. In fact, many scales to measure frailty have emerged without gold standard.

The SEGAm showed its usefulness in aged patients living at home.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Frailty Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

75 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Maison de Santé Pluridisciplinaire de Bar sur Seine

Bar-sur-Seine, Grand Est, 10110, France

About this study

The aim of the study is to describe prevalence of frailty in patients aged of 75 and more living at home.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

male or female
aged of 75 and more
living at home
agreeing to participate in the study

Exclusion criteria

none

Treatment and study plan

Data Collection

Other

frailty evaluation

Primary outcomes

Frailty

Time frame: Day 0

Frailty evaluated using SEGA modified scale (SEGAm). SEGAm includes 13 items (coded from 0 to 2) to obtain a global score out of 26 points. Patients with a score less than or equal to 8 are considered not fragile. Patients with a score between 8 and 11 are considered fragile. Patients with a score greater than or equal to 11 are considered very fragile.

Sponsors and collaborators

Lead sponsor

Université de Reims Champagne-Ardenne

Other

Registry information

Acronym: FRAIL-DOM

Important dates

Study start: 2022
Primary completion: 2022
Study completion: 2022
First posted: Dec 20, 2021
Registry last updated: Mar 10, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed